Nirmish Shah
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| AB1 in Adult Patients with Sickle Cell Disease (SCD) (NCT05261711) | Nirmish Shah | 2022-12-05 |
| Apixaban in Patients With Sickle Cell Disease (NCT02179177) | Nirmish Shah | 2015-01-01 |
Track Nirmish Shah automatically
Every clearance here is in the API, with alerts when new ones post.